Inotiv offers a broad scope of expertise for drug metabolism and pharmacokinetics (DMPK) studies at all stages of R&D, from lead optimization through new drug application (NDA). Benefit from our long and impeccable regulatory history, world-class team of scientists, and 40+ year track record of providing leading pharma and biotech companies with attentive, decisive analytical services — and high-quality data.
Our stage-dependent drug discovery bundles offer you the solutions you need to provide you with the insights to make informed decisions.
To talk to an expert about our DMPK Services, please click here.
At Inotiv, you have access to a broad range of In Vivo Discovery Pharmacokinetics and exploratory toxicology support including:
Rodent In Vivo Drug Disposition Models:
Get More Insight into our In Vivo Services
Whatever the source of your data, we will perform PK-TK analyses to evaluate dose, DDI potential, bioequivalence/bioavailability, and/or clinical PK projections. You benefit from:
Our experts deliver the insights you deserve to get the answers you need, whether in DMPK data analysis, biomarker analysis, or bioequivalence studies.